Listar por tema "Cirrhosis"
Mostrando ítems 1-3 de 3
-
Effectiveness and safety of sofosbuvir‐based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis: results of a multicenter real‐life cohort
(Wiley, 2016-11-09)[Abstract] Patients with HCV genotype 3 (GT3) infection and cirrhosis are currently the most difficult to cure. We report our experience with sofosbuvir+daclatasvir (SOF+DCV) or sofosbuvir/ledipasvir (SOF/LDV), with or ... -
High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4
(Wiley, 2017-05-08)[Abstract] Background and Aims. Hepatitis C (HCV) therapy with Sofosbuvir (SOF)/Simeprevir (SMV) in clinical trials and real‐world clinical practice, showed high rates of sustained virological response (SVR) in non‐cirrhotic ... -
Linfedema grave tipo elefantiasis secundario a insuficiencia hepática crónica alcohólica
(Universidade da Coruña, 2016)[Resumen] El cúmulo de líquido linfático a nivel subcutáneo en una determinada región corporal y/o extremidad se denomina linfedema. Existen dos tipos fundamentales de linfedema: primario o hereditario, y secundario o ...